Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial - The Lancet Neurology

PDF) Safety and efficacy of tenecteplase versus alteplase in patients with acute ischaemic stroke (TRACE): a multicentre, randomised, open label, blinded- endpoint (PROBE) controlled phase II study

Tenecteplase in Ischemic Stroke

Journal of Stroke

Journal of Stroke

Thrombolysis for acute ischaemic stroke: current status and future perspectives - The Lancet Neurology

Alteplase Archives - REBEL EM - Emergency Medicine Blog

Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial - The Lancet

Tenecteplase in Ischemic Stroke

Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke

PDF) Tenecteplase Versus Alteplase Between 3 and 4.5 Hours in Low National Institutes of Health Stroke Scale

Prospective Observational Cohort Study of Tenecteplase Versus Alteplase in Routine Clinical Practice

Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study - The Lancet Neurology

Journal club nortest trial